SCHEMBL6479407

SCHEMBL6479407

CCc1[nH]c2ccccc2c1Cc1ccc([C]=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.44
MMP3 P08254 1/20 0.44
MMP7 P09237 1/20 0.44
MMP12 P39900 1/20 0.44
CHRNB2 P17787 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
HPGD P15428 2/20 0.41
TSHR P16473 2/20 0.41
CYP2C19 P33261 2/20 0.41
MTNR1A P48039 2/20 0.41
MTNR1B P49286 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MEN1 O00255 1/20 0.41
CYP2C9 P11712 1/20 0.41
KMT2A Q03164 1/20 0.41
KIF11 P52732 1/20 0.41
ALDH1A1 P00352 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479409 0.83 KIF11 (0.46) MMP2MMP3MMP7MMP12CHRNB2
SCHEMBL4443609 0.83 ALDH1A1 (0.50) MMP3MMP7MMP12CYP3A4HPGD
SCHEMBL6993933 0.81 MAPT (0.49) MMP2MMP3MMP7MMP12CHRNB2
SCHEMBL14979205 0.78 MEN1 (0.46) MMP2MMP3MMP7MMP12MEN1
SCHEMBL6882102 0.77 HTT (0.55) CHRNB2CHRNA7CHRNA4CYP3A4TSHR
Water SCHEMBL11540986 0.75 HTT (0.53) CHRNB2CHRNA7CHRNA4CYP3A4TSHR
SCHEMBL31034424 0.72 HPGD (0.58) CHRNB2CHRNA7CHRNA4CYP3A4CYP1A2
SCHEMBL14193990 0.71 CHRNB2 (0.64) CHRNB2CHRNA7CHRNA4CYP3A4CYP1A2
SCHEMBL22132140 0.71 CHRNB2 (0.47) CHRNB2CHRNA7CHRNA4CYP3A4TSHR
SCHEMBL5459223 0.71 ALDH1A1 (0.50) CHRNB2CHRNA7CHRNA4CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed